A short-term (accelerated release) approach to evaluate peptide release from plga depot formulations

AAPS Journal

Volumn 1, Issue 3, 1999, Pages

  Shameem, Mohammed ^a   Lee, Heeyong ^a   DeLuca, Patrick P ^a  

^a University of Kentucky   (United States)

Author keywords

Depot formulation, accelerated release, elevated temperature, plga; Peptide loaded microspheres

Indexed keywords

EID: 53149130960     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Holden C. Drugs and biotechnology. Science. 1994;248:964.
2. Okada H, Heya T, Ogawa Y, Shimamoto T. One month release injectable microcapsules of a lutenizing hormone-releasing hormone agonist (leuprolide acetate) for treating experimental endometrosis in rats. J Pharm Exp Ther. 1988;244:744-750.
3. Walker KJ, Turkes AO, Turkes A, Zwink R, Beacock C, Buck, AC, Peeling WB, Griffiths K. Treatment of patients with advanced cancer of the prostate using a slow-release (depot) formulation of the LHRH agonist ICI 118630 (Zoladex). J Endocrinol. 1984;103:R1-R4.
4. Eldrige JH, Staas JK, Meulbroek JA, Tice TR, Gilley RM. Biodegradable and biocompatible poly(dl-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin neutralizing antibodies. Infect. Immun. 1991;59:2978-2986.
5. Bergsma JE, Rozema FR, Bos RR, Boering G, de Bruijn WC, Pennings AJ. In vivo degradation and biocompatability study of in vitro pre-degraded as-polymerized polylactide particles. Biomaterials. 1996;16:267-274.
6. Aso Y, Yoshiyoka S, Wan Po E, Terao T. Effect of temperature on mechanisms of drug release and matrix degradation of poly (D,Elactide) microspheres. J Control Release. 1994;31:33-39.
7. Kaniwa N, Shameem M, Katori N, Aoyagi N, Kojima S. The suitable temperature for the evaluation of controlled release products in vitro. Pharmazie. 1995;50:53-55.
8. Cha Y, Pitt CG. The acceleration of degradation-controlled drug delivery from polyester microspheres. J Control Release. 1989;8:259265.
9. DeLuca PP, Mehta RC, Hausberger AG, Thanoo BC. Biodegradable polyesters for drug and polypeptide delivery. In: ELNokaly MA, Piatt DM, Charpentier BA, eds. Polymer Delivery Systems, Properties and Applications. ACS Symposium Series 520. Washington, DC: American Chemical Society; 1993:53-79.
10. Shameem M, Lee H, Burton K, Thanoo BC, DeLuca, PP. Lffect of -irradiation on peptide-containing hydrophilic poly (d,l-lactide-coglycolide) microspheres. J Pharm Sei Tech. (1999). In press.
11. Mehta RC, Thanoo BC, DeLuca PP. Peptide containing microspheres from low molecular weight and hydrophilic poly(d,llactide-co-glycolide). J Control Release. 1996;41:249-257.
12. Okada H, Doken Y, Ogawa Y, Toguchi H. Preparation of threemonth depot injectable microspheres of leuprorelin acetate using biodegradable polymers. Pharm Res. 1994;! 1:1143-1147.
13. Park TG, Lu W, Crotts G. Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly (d,l-lactide-co-glycolide) microspheres. J Control Release. 1995;33:211-222.
14. Mader K, Gallez B, Liu KJ, Swartz, HM. Non-invasive in vivo characterization of release processes in biodegradable polymers by low-frequency electron paramagnetic resonance spectroscopy. Biomaterials. 1996;17:457-461.